Human PDCD1 / PD-1 / CD279 Antibody (Retifanlimab, Research Use)

产品名称	Human PDCD1 / PD-1 / CD279 Antibody (Retifanlimab, Research Use)
目录号	NBR-0842
别名	CD279; hSLE1; PD-1; PD1; SLEB2
外观	Transparent Liquid
分子量	150kDa
CAS	N/A
溶解度	Water, PBS, TBS Buffer,etc.
存储条件	Temp. -80℃
保存时间	see COA
备注1	CHO Expressed
备注2	Ab. Isotype - IgG

目录号	规格	价格	库存状态
NBR-0842-100UG	100ug	￥550	请咨询
NBR-0842-1MG	1mg	￥3500	请咨询
NBR-0842-5MG	5mg	￥7500	请咨询

【产品概况】

产品名称：Human PDCD1 / PD-1 / CD279 Antibody (Retifanlimab, Research Use)
产品编号：NBR-0842
针对靶点：PDCD1 / PD-1 / CD279
抗体药商品名：Retifanlimab
抗体药描述：Retifanlimab (previously known as MGA012) is an investigational, humanized, proprietary anti-PD-1 monoclonal antibody being developed for use as monotherapy as well as in combination with other potential cancer therapeutics. Retifanlimab was licensed to Incyte Corporation in 2017 under a global collaboration and license agreement.

【产品参数】

产品外观：Transparent Liquid
分子量：~150kDa
CAS：N/A
溶解度：Water; PBS, TBS Buffer等
表达系统：CHO Expressed
抗体亚型：Ab. Isotype - IgG

【基因信息】

Gene Name: PDCD1
Synonyms: CD279; hSLE1; PD-1; PD1; SLEB2
Target Description: Inhibitory receptor on antigen activated T-cells that plays a critical role in induction and maintenance of immune tolerance to self. Delivers inhibitory signals upon binding to ligands CD274/PDCD1L1 and CD273/PDCD1LG2.
Ensembl: ENSG00000188389
Uniprot: Q15116